Boosting of Cellular Immunity against Mycobacterium tuberculosis and Modulation of Skin Cytokine Responses in Healthy Human Volunteers by Mycobacterium bovis BCG Substrain Moreau Rio de Janeiro Oral Vaccine
Open Access
- 1 April 2006
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 74 (4) , 2449-2452
- https://doi.org/10.1128/iai.74.4.2449-2452.2006
Abstract
Oral immunization of healthy adults with 10 7 CFU BCG Moreau Rio de Janeiro was well tolerated and significantly boosted gamma interferon responses to purified protein derivative, Ag85, and MPB70 from previous childhood intradermal BCG immunization. Oral BCG offers the possibility of a needle-free tuberculosis vaccine and of boosting the protective immunity from intradermal tuberculosis vaccines.Keywords
This publication has 21 references indexed in Scilit:
- Effect of BCG revaccination on incidence of tuberculosis in school-aged children in Brazil: the BCG-REVAC cluster-randomised trialThe Lancet, 2005
- Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosisVaccine, 2005
- Recombinant modified vaccinia virus Ankara expressing antigen 85A boosts BCG-primed and naturally acquired antimycobacterial immunity in humansNature Medicine, 2004
- Mycobacterium bovis BCG-based vaccines against tuberculosis: novel developmentsVaccine, 2003
- A meta-analysis of the effect of Bacille Calmette Guerin vaccination on tuberculin skin test measurementsThorax, 2002
- Recombinant BCG vaccinesVaccine, 2001
- Enhanced contact tracing and spatial tracking of Mycobacterium tuberculosis infection by enumeration of antigen-specific T cellsThe Lancet, 2001
- Propelling novel vaccines directed against tuberculosis through the regulatory processTubercle and Lung Disease, 1999
- Bacillus Calmette-Guérin Revaccination Questionable with Low Tuberculosis IncidenceAmerican Journal of Respiratory and Critical Care Medicine, 1998
- Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in MalawiThe Lancet, 1996